Ensuring DSCSA Compliance: A Guide for Hospitals ## Breadcrumb 1. [Home](/) # Ensuring DSCSA Compliance: A Guide for Hospitals ![banner-image](https://www.tracelink.com/sites/default/files/2024-03/Digital%20Recalls%20Innovation%202.png) The[ **Drug Supply Chain Security Act (DSCSA)**](/product-orchestration/country-compliance/us-compliance) is a federal law in the United States that aims to enhance the security and traceability of pharmaceutical products throughout the supply chain. For [**hospitals**](/supply-chain-orchestration/healthcare-provider), compliance with DSCSA is crucial to ensure patient safety, prevent counterfeit drugs, and maintain transparency. ## What is DSCSA compliance? The DSCSA provides a framework for tracing prescription drugs as they are distributed across the United States. Key components of the DSCSA include: - **Product Tracing:** Requires trading partners to provide detailed information regarding every product transaction, ensuring traceability from manufacturer to dispenser. This includes exchanging serialized T2 information as part of an EPCIS transaction. - **Product Verification:** Mandates the ability to verify the legitimacy of the product identifier as part of a suspect product investigation or salable return. - **Detection and Response:** Establishes systems and processes to identify and handle suspect and illegitimate products. - **Notification:** Requires notification of the FDA and other stakeholders about illegitimate products. ## DSCSA Guidance: Compliance Requirements for Hospitals - **DSCSA Serialization:** Hospitals must ensure that all prescription drugs are serialized according to DSCSA guidelines. This involves updating systems and processes to handle serialized products. - **Verification:** Hospitals should verify the authenticity of received drug products using authorized systems. - **Maintaining Transaction Documentation:** Hospitals must maintain records of transaction information, transaction history, and transaction statements (commonly referred to as T3 information ) for a minimum of six years. Additionally, at the end of the stabilization period, T3 will transition into a [**serialized T2**](/resources/resource-center/requirements-for-transitioning-from-nonserialized-t3-to-serialized-t2). - **Suspect Product Investigations:** Hospitals need to establish protocols for identifying, investigating, and reporting suspect or illegitimate products to the FDA and trading partners. - **Utilizing Compliance Software:** Implementing specialized compliance software can streamline the management of DSCSA requirements. These systems can automate record-keeping, facilitate verification processes, and ensure timely reporting. ## Challenges Faced by Hospitals in DSCSA Compliance: - **Complexity:** Implementing serialization and maintaining accurate records can be complex and resource-intensive. - **Worflow:** Introduces an additional “check” and potential scan of the product during intake, which as more work to hospital pharmacy staff. - **Integration:** Hospitals need to integrate their systems with other supply chain partners (manufacturers, wholesalers, etc.). - **Training:** Staff must be trained on DSCSA requirements and compliance procedures. - **Data Management:** Maintaining and managing large volumes of transaction data over six years requires robust data management solutions. - **Coordination with Trading Partners:** Effective communication and coordination with manufacturers, wholesalers, and other trading partners are critical to ensure seamless compliance. ## Penalties for Non-Compliance: - **Patient Safety:** Patients could be put at risk if counterfeit or adulterated product is dispensed. - **Monetary Fines:** The FDA can impose substantial fines on hospitals for failing to comply with DSCSA requirements. - **Legal Action:** Persistent non-compliance can lead to legal actions, including lawsuits and injunctions. - **Reputation Damage:** Non-compliance can harm a hospital's reputation, leading to a loss of trust among patients and partners. ## DSCSA Exemptions and Special Cases: Certain products and scenarios are exempt from DSCSA requirements. These include: - **Blood and Blood Components:** Blood and blood components intended for transfusion are exempt from DSCSA regulations. - **Medical Convenience Kits:** Kits that include drugs and are intended for the convenience of the patient or healthcare provider may be exempt under specific conditions. - **Certain Intravenous Products:** Products that are for fluid replacement, irrigation, or nutritional support may also be exempt. ## Role of DSCSA Compliance Software: - **Track and Trace Solutions:** Hospitals can use specialized software to track drug movements, verify authenticity, and maintain compliance records. - **Automated Reporting:** Compliance software streamlines reporting processes, reducing manual effort. - **Auditing and Monitoring:** Regular audits using software help hospitals identify gaps and ensure ongoing compliance. Contact us to learn more about DSCSA! Fill out the form to schedule a meeting with us now. document.addEventListener("DOMContentLoaded", function() { // Delay the execution by 2 seconds (2000 milliseconds) setTimeout(function() { (function() { 'use strict'; // Load Marketo form MktoForms2.loadForm("//go.tracelink.com", "776-BAW-230", 2259); })(); // Wait until the Marketo form is loaded MktoForms2.whenReady(function(form) { var formElement = document.getElementById('mktoForm_2259'); if (!formElement) { console.error("Form with id 'mktoForm_2259' not found."); return; } var formLocation = formElement.querySelector("input[name=formLocation]"); // Get the current URL and set the formLocation field if (formLocation) { var currentURL = window.location.href; formLocation.value = currentURL; } // Add onSuccess handler form.onSuccess(function(values, followUpUrl) { var formElem = form.getFormElem()[0]; if (formElem) { formElem.style.display = 'none'; } else { console.warn("Form element could not be found to hide it."); } var confirmMessage = document.getElementById('confirmform'); if (confirmMessage) { confirmMessage.style.display = 'block'; } else { console.warn("Confirmation message with id 'confirmform' not found."); } return false; // Prevent the form from submitting normally }); }); }, 2000); // Delay for 2 seconds }); **Thank you for contacting us; we’ll be in touch shortly.** ##### Related Content [ ![Image of person holding blister packs.](https://www.tracelink.com/sites/default/files/styles/resize_image_style_640_480/public/2024-03/retail-pharmacy-stat-component-background.png.webp?itok=e_K2rlfU) ](/resources/resource-center/dscsa-compliance-for-independent-pharmacies-essentials) ##### DSCSA 2023 Compliance for Independent Pharmacies: The Need-to-Know Essentials Complying with DSCSA can be difficult. Download this brief to see how TraceLink helps independent dispensers meet the mandate with a turnkey DSCSA solution. [View More](/resources/resource-center/dscsa-compliance-for-independent-pharmacies-essentials) [ ![DSCSA](https://www.tracelink.com/sites/default/files/styles/resize_image_style_640_480/public/2024-03/For%20Internal%205.png.webp?itok=AzflfAgI) ](/resources/resource-center/dscsa-compliance-pharmacies-video) ##### TraceLink: Making DSCSA Compliance Easy for Pharmacies See how TraceLink makes DSCSA compliance fast and easy for health systems and retail pharmacies. Watch the video. [View More](/resources/resource-center/dscsa-compliance-pharmacies-video)